Healthconn Corp (6665.TWO) Q4 2025 Earnings Report

Healthconn Corp reported a solid Q4 2025 showing despite a backdrop of volatility in quarterly profitability. Revenue for the quarter was 583.1 million TWD, down 11.14% versus Q4 2024, while gross profit stood at 112.92 million TWD for a gross margin of 19.37%. EBITDA was 8.08 million TWD with an operating income of 8.08 million TWD and an operating margin of 1.39%. Net income totaled 11.79 million TWD, corresponding to a net margin of 2.02% and EPS of 0.26. A notable feature of the quarter was the contribution from total other income and expenses net of 9.01 million TWD, which lifted income before tax to 17.09 million TWD and amplified pretax profitability beyond what the core operations would generate alone.

Compared with Q4 2024, revenue declined modestly, and net income fell from 19.02 million TWD to 11.79 million TWD (approximate -38% YoY), signaling that the quarterly uplift was driven by non-operating items rather than a sustained improvement in operating performance. The results imply the business remains resilient at the revenue level while bottom-line profitability is more sensitive to non-operating items in the reported quarter. Management commentary is not publicly provided in the data set; consequently forward guidance and qualitative commentary on strategic initiatives require cautious interpretation. Investors should monitor core operating leverage, cost discipline, and any variability in non-operating income sources as key near-term determinants of profitability.